Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$51,452,873
-$839,981 QoQ
Shares Held
892,969
+3.6% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#166
of 2,514 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $386,755,559 across 13 Drug Manufacturers - General names. BMY ranks #3 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
528,937 | $67,968,404 | |
| 2 | BIIB |
Biogen Inc.
|
279,900 | $60,475,194 | |
| 3 | BMY |
Bristol Myers Squibb Co
This page
|
892,969 | $51,452,873 | |
| 4 | JNJ |
Johnson & Johnson
|
200,512 | $50,924,032 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
381,851 | $48,243,055 | |
| 6 | ABBV |
AbbVie Inc.
|
108,867 | $27,395,291 | |
| 7 | LLY |
ELI LILLY & Co
|
21,971 | $26,352,678 | |
| 8 | PFE |
Pfizer Inc
|
916,205 | $22,062,216 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,452,873 | 892,969 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $52,292,854 | 862,207 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $42,227,899 | 782,868 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $31,489,902 | 698,224 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $28,143,671 | 607,986 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,111,163 | 296,953 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,584,655 | 275,542 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,436,845 | 337,009 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,912,382 | 286,838 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $18,774,968 | 346,210 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $13,296,986 | 259,150 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $12,037,786 | 207,405 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,931,115 | 155,295 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,365,846 | 91,846 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $13,264,558 | 184,358 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,183,830 | 171,386 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,673,664 | 125,632 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,832,394 | 107,249 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,245,038 | 100,161 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,608,132 | 94,780 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $304,899 | 4,563 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $4,131,011 | 66,597 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,476,834 | 140,601 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $21,169,587 | 360,027 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $14,776,618 | 265,099 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||